Your browser doesn't support javascript.
loading
BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers.
Mahmoudi, Asma; Jaafari, Mahmoud Reza; Ramezanian, Navid; Gholami, Leila; Malaekeh-Nikouei, Bizhan.
Affiliation
  • Mahmoudi A; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Jaafari MR; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ramezanian N; Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran.
  • Gholami L; Targeted Drug Delivery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Malaekeh-Nikouei B; Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Institute of Pharmaceutical Technology, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: malaekehb@mums.ac.ir.
Int J Pharm ; 564: 77-89, 2019 Jun 10.
Article in En | MEDLINE | ID: mdl-30991135

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Drug Carriers / Dendrimers / Nanoparticles / Irinotecan / Antineoplastic Agents, Phytogenic Limits: Animals / Female / Humans Language: En Journal: Int J Pharm Year: 2019 Document type: Article Affiliation country: Iran

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Drug Carriers / Dendrimers / Nanoparticles / Irinotecan / Antineoplastic Agents, Phytogenic Limits: Animals / Female / Humans Language: En Journal: Int J Pharm Year: 2019 Document type: Article Affiliation country: Iran